share_log

睿昂基因(688217.SH):股东浙江大健康拟减持合计不超过2%股份

Ruiong Gene (688217.SH): Shareholder Zhejiang Health plans to reduce its shareholding by no more than 2%.

Gelonghui Finance ·  Jun 4 16:34

On ****, Gelonhui reported that due to the shareholder's own capital needs, shareholder Zhejiang Dajiankang intends to reduce its total holdings of the company's shares through centralized bidding and bulk trading by no more than 1,117,116 shares, accounting for no more than 2% of the total share capital of the company.

Shareholder Zhejiang Dajiankang plans to reduce its holdings of the company's shares through centralized bidding by no more than 558,558 shares, accounting for no more than 1% of the total share capital of the company, and through bulk trading by no more than 558,558 shares, accounting for no more than 1% of the total share capital of the company. In any continuous 90 natural days, the total number of shares held during the reduction period shall not exceed 1% of the total number of shares of the company. The reduction through centralized bidding and bulk trading shall be carried out within 3 months after 15 trading days from the date of this announcement. The reduction price is determined according to the market price.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment